 Niranjan Karnik
Concepts (326)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 8 | 2022 | 50 | 5.290 |
Why?
| | Mental Disorders | 12 | 2021 | 202 | 3.880 |
Why?
| | Veterans | 8 | 2021 | 70 | 2.730 |
Why?
| | Stress Disorders, Post-Traumatic | 11 | 2021 | 204 | 2.660 |
Why?
| | Homeless Youth | 5 | 2021 | 12 | 2.560 |
Why?
| | Substance-Related Disorders | 7 | 2021 | 111 | 2.550 |
Why?
| | Homeless Persons | 4 | 2021 | 12 | 2.490 |
Why?
| | Electronic Health Records | 8 | 2021 | 77 | 2.380 |
Why?
| | Mental Health Services | 6 | 2021 | 61 | 2.300 |
Why?
| | Adolescent | 40 | 2021 | 2627 | 2.270 |
Why?
| | Psychiatry | 3 | 2021 | 14 | 2.230 |
Why?
| | Prescription Drug Misuse | 3 | 2019 | 6 | 2.230 |
Why?
| | Primary Health Care | 4 | 2020 | 100 | 1.830 |
Why?
| | Antipsychotic Agents | 5 | 2021 | 90 | 1.820 |
Why?
| | Depressive Disorder | 4 | 2019 | 213 | 1.800 |
Why?
| | Humans | 76 | 2022 | 30741 | 1.740 |
Why?
| | Prisoners | 6 | 2013 | 18 | 1.730 |
Why?
| | Juvenile Delinquency | 8 | 2011 | 15 | 1.690 |
Why?
| | Inpatients | 4 | 2020 | 147 | 1.610 |
Why?
| | Gender Identity | 2 | 2021 | 18 | 1.560 |
Why?
| | Analgesics, Opioid | 3 | 2021 | 198 | 1.500 |
Why?
| | Aggression | 5 | 2018 | 35 | 1.500 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2021 | 36 | 1.440 |
Why?
| | Research Design | 3 | 2021 | 230 | 1.430 |
Why?
| | Young Adult | 19 | 2021 | 2249 | 1.340 |
Why?
| | Child Psychiatry | 3 | 2018 | 15 | 1.310 |
Why?
| | Child | 17 | 2021 | 1547 | 1.220 |
Why?
| | Female | 48 | 2021 | 18107 | 1.200 |
Why?
| | Foster Home Care | 2 | 2017 | 4 | 1.180 |
Why?
| | Male | 46 | 2021 | 17552 | 1.180 |
Why?
| | Nurse Practitioners | 2 | 2018 | 114 | 1.170 |
Why?
| | Health Services Accessibility | 4 | 2022 | 111 | 1.160 |
Why?
| | Patient Discharge | 3 | 2021 | 160 | 1.150 |
Why?
| | Referral and Consultation | 3 | 2021 | 93 | 1.140 |
Why?
| | Natural Language Processing | 5 | 2021 | 7 | 1.050 |
Why?
| | Vulnerable Populations | 2 | 2020 | 26 | 1.050 |
Why?
| | United States | 15 | 2021 | 2467 | 1.040 |
Why?
| | Buprenorphine | 1 | 2022 | 5 | 0.960 |
Why?
| | National Institute on Drug Abuse (U.S.) | 1 | 2021 | 1 | 0.900 |
Why?
| | Delphi Technique | 1 | 2021 | 23 | 0.890 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2021 | 30 | 0.890 |
Why?
| | Length of Stay | 2 | 2020 | 371 | 0.890 |
Why?
| | Risk-Taking | 3 | 2019 | 40 | 0.880 |
Why?
| | Adult | 24 | 2021 | 9760 | 0.870 |
Why?
| | Consensus | 1 | 2021 | 96 | 0.850 |
Why?
| | Cultural Diversity | 3 | 2004 | 30 | 0.830 |
Why?
| | Alcoholism | 5 | 2020 | 87 | 0.810 |
Why?
| | Adolescent Psychiatry | 2 | 2018 | 8 | 0.810 |
Why?
| | Bullying | 1 | 2019 | 3 | 0.800 |
Why?
| | Crime Victims | 1 | 2019 | 15 | 0.780 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 83 | 0.780 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 30 | 0.760 |
Why?
| | Psychotropic Drugs | 2 | 2017 | 29 | 0.760 |
Why?
| | Community Health Centers | 1 | 2018 | 14 | 0.750 |
Why?
| | Interprofessional Relations | 1 | 2018 | 45 | 0.720 |
Why?
| | Disclosure | 1 | 2018 | 16 | 0.720 |
Why?
| | Conflict of Interest | 1 | 2018 | 19 | 0.710 |
Why?
| | Depression | 3 | 2019 | 502 | 0.710 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 82 | 0.710 |
Why?
| | Publishing | 1 | 2018 | 36 | 0.700 |
Why?
| | Informed Consent | 1 | 2017 | 24 | 0.670 |
Why?
| | Drug Discovery | 1 | 2017 | 30 | 0.670 |
Why?
| | Meaningful Use | 1 | 2016 | 3 | 0.660 |
Why?
| | Middle Aged | 17 | 2021 | 11256 | 0.640 |
Why?
| | Social Behavior | 1 | 2017 | 109 | 0.640 |
Why?
| | Mental Health | 4 | 2021 | 114 | 0.630 |
Why?
| | Social Media | 2 | 2017 | 32 | 0.630 |
Why?
| | Psychology, Adolescent | 3 | 2011 | 9 | 0.620 |
Why?
| | Adolescent Behavior | 3 | 2014 | 30 | 0.620 |
Why?
| | Students, Medical | 3 | 2004 | 45 | 0.610 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 239 | 0.600 |
Why?
| | HIV Infections | 2 | 2020 | 915 | 0.590 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 386 | 0.580 |
Why?
| | Social Support | 2 | 2016 | 217 | 0.570 |
Why?
| | Antisocial Personality Disorder | 2 | 2011 | 11 | 0.570 |
Why?
| | Military Personnel | 3 | 2019 | 40 | 0.540 |
Why?
| | Physicians | 1 | 2015 | 112 | 0.540 |
Why?
| | Education, Medical, Graduate | 3 | 2018 | 82 | 0.520 |
Why?
| | Veterans Health | 1 | 2013 | 3 | 0.520 |
Why?
| | Rape | 1 | 2013 | 7 | 0.520 |
Why?
| | Sexually Transmitted Diseases | 1 | 2012 | 16 | 0.490 |
Why?
| | Adolescent Development | 1 | 2012 | 6 | 0.490 |
Why?
| | Attitude of Health Personnel | 2 | 2004 | 179 | 0.490 |
Why?
| | Group Processes | 1 | 2012 | 15 | 0.490 |
Why?
| | Child, Preschool | 6 | 2021 | 803 | 0.480 |
Why?
| | Valproic Acid | 2 | 2009 | 31 | 0.480 |
Why?
| | Family Therapy | 1 | 2011 | 1 | 0.480 |
Why?
| | Systems Theory | 1 | 2011 | 4 | 0.480 |
Why?
| | Refugees | 4 | 2014 | 25 | 0.470 |
Why?
| | Ambulatory Care Facilities | 3 | 2021 | 41 | 0.470 |
Why?
| | Chicago | 4 | 2019 | 945 | 0.460 |
Why?
| | Teaching | 3 | 2010 | 62 | 0.450 |
Why?
| | Stress, Psychological | 2 | 2018 | 278 | 0.450 |
Why?
| | Treatment Outcome | 7 | 2021 | 3850 | 0.450 |
Why?
| | Ethnopsychology | 1 | 2010 | 1 | 0.440 |
Why?
| | Cultural Competency | 1 | 2010 | 15 | 0.430 |
Why?
| | Central Nervous System Stimulants | 2 | 2016 | 56 | 0.430 |
Why?
| | Housing | 2 | 2021 | 17 | 0.430 |
Why?
| | Models, Educational | 1 | 2010 | 39 | 0.430 |
Why?
| | Urban Population | 1 | 2011 | 158 | 0.430 |
Why?
| | Morals | 2 | 2020 | 15 | 0.400 |
Why?
| | Criminal Psychology | 1 | 2009 | 1 | 0.390 |
Why?
| | Criminals | 1 | 2009 | 1 | 0.390 |
Why?
| | Crime | 1 | 2009 | 9 | 0.390 |
Why?
| | Temperament | 1 | 2009 | 13 | 0.390 |
Why?
| | Impulsive Behavior | 1 | 2009 | 21 | 0.380 |
Why?
| | Sexual Behavior | 2 | 2021 | 66 | 0.380 |
Why?
| | Patient Readmission | 2 | 2020 | 124 | 0.380 |
Why?
| | Character | 1 | 2008 | 3 | 0.370 |
Why?
| | Curriculum | 3 | 2004 | 153 | 0.370 |
Why?
| | Sex Offenses | 2 | 2018 | 24 | 0.370 |
Why?
| | Aged | 9 | 2021 | 10156 | 0.360 |
Why?
| | Mass Screening | 2 | 2020 | 199 | 0.360 |
Why?
| | Arousal | 1 | 2008 | 56 | 0.360 |
Why?
| | Mobile Applications | 2 | 2019 | 33 | 0.360 |
Why?
| | Infant, Newborn | 2 | 2021 | 751 | 0.360 |
Why?
| | Cognition | 4 | 2021 | 1141 | 0.350 |
Why?
| | Aphasia, Primary Progressive | 1 | 2006 | 2 | 0.340 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 2 | 2006 | 5 | 0.340 |
Why?
| | Violence | 2 | 2017 | 36 | 0.340 |
Why?
| | Delirium | 1 | 2007 | 39 | 0.340 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2006 | 24 | 0.330 |
Why?
| | Psychopathology | 1 | 2006 | 6 | 0.330 |
Why?
| | Supranuclear Palsy, Progressive | 1 | 2006 | 44 | 0.330 |
Why?
| | Self Disclosure | 1 | 2006 | 13 | 0.330 |
Why?
| | Hospitalization | 2 | 2020 | 344 | 0.330 |
Why?
| | Prevalence | 7 | 2014 | 546 | 0.320 |
Why?
| | Comorbidity | 4 | 2020 | 562 | 0.310 |
Why?
| | Rhabdomyolysis | 1 | 2005 | 7 | 0.310 |
Why?
| | Transaminases | 1 | 2005 | 9 | 0.310 |
Why?
| | Simvastatin | 1 | 2005 | 15 | 0.310 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2005 | 31 | 0.310 |
Why?
| | Hypolipidemic Agents | 1 | 2005 | 28 | 0.300 |
Why?
| | Triazoles | 1 | 2005 | 35 | 0.300 |
Why?
| | Antidepressive Agents | 1 | 2005 | 107 | 0.300 |
Why?
| | Prejudice | 2 | 2003 | 42 | 0.290 |
Why?
| | California | 3 | 2010 | 34 | 0.290 |
Why?
| | Education, Medical, Undergraduate | 1 | 2004 | 36 | 0.280 |
Why?
| | Education, Medical | 1 | 2004 | 45 | 0.280 |
Why?
| | Algorithms | 1 | 2007 | 421 | 0.280 |
Why?
| | Pediatrics | 2 | 2020 | 48 | 0.270 |
Why?
| | Sex Factors | 5 | 2020 | 535 | 0.270 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2020 | 24 | 0.260 |
Why?
| | African Americans | 1 | 2010 | 780 | 0.250 |
Why?
| | Yoga | 2 | 2020 | 10 | 0.240 |
Why?
| | Tertiary Care Centers | 2 | 2019 | 83 | 0.240 |
Why?
| | Opiate Substitution Treatment | 1 | 2022 | 2 | 0.240 |
Why?
| | Education, Continuing | 1 | 2022 | 14 | 0.240 |
Why?
| | Internship and Residency | 2 | 2018 | 187 | 0.240 |
Why?
| | Psychotherapy, Group | 2 | 2019 | 40 | 0.230 |
Why?
| | Dementia | 1 | 2006 | 509 | 0.230 |
Why?
| | Mindfulness | 2 | 2020 | 42 | 0.230 |
Why?
| | Minority Groups | 1 | 2001 | 71 | 0.220 |
Why?
| | Endpoint Determination | 1 | 2021 | 31 | 0.220 |
Why?
| | Patients | 1 | 2021 | 26 | 0.220 |
Why?
| | Data Collection | 1 | 2021 | 118 | 0.220 |
Why?
| | Behavior, Addictive | 1 | 2020 | 11 | 0.220 |
Why?
| | Psychotherapy | 1 | 2021 | 42 | 0.220 |
Why?
| | Prognosis | 2 | 2019 | 1045 | 0.210 |
Why?
| | Communication | 1 | 2001 | 119 | 0.210 |
Why?
| | Forecasting | 1 | 2020 | 130 | 0.210 |
Why?
| | Psychotherapy, Brief | 1 | 2020 | 5 | 0.210 |
Why?
| | Homosexuality, Male | 1 | 2020 | 26 | 0.210 |
Why?
| | Hospitals | 1 | 2021 | 131 | 0.210 |
Why?
| | Social Adjustment | 2 | 2017 | 32 | 0.200 |
Why?
| | Insurance Coverage | 1 | 2019 | 17 | 0.200 |
Why?
| | Cross-Sectional Studies | 4 | 2017 | 957 | 0.200 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 385 | 0.200 |
Why?
| | Suicide, Attempted | 1 | 2019 | 20 | 0.200 |
Why?
| | Trauma Centers | 1 | 2019 | 13 | 0.200 |
Why?
| | Global Health | 1 | 2019 | 57 | 0.190 |
Why?
| | Physician-Patient Relations | 2 | 2013 | 47 | 0.190 |
Why?
| | Models, Theoretical | 1 | 2019 | 109 | 0.190 |
Why?
| | Behavioral Symptoms | 1 | 2018 | 17 | 0.190 |
Why?
| | HIV | 1 | 2019 | 88 | 0.190 |
Why?
| | Wounds and Injuries | 1 | 2019 | 57 | 0.190 |
Why?
| | Personality Inventory | 2 | 2009 | 87 | 0.190 |
Why?
| | Conduct Disorder | 2 | 2009 | 3 | 0.180 |
Why?
| | Hydrocortisone | 1 | 2018 | 57 | 0.180 |
Why?
| | Fellowships and Scholarships | 1 | 2018 | 35 | 0.180 |
Why?
| | Occupational Diseases | 1 | 2018 | 26 | 0.180 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 116 | 0.180 |
Why?
| | Survivors | 1 | 2018 | 64 | 0.180 |
Why?
| | Iatrogenic Disease | 1 | 2017 | 26 | 0.170 |
Why?
| | Infant | 1 | 2019 | 660 | 0.170 |
Why?
| | Minors | 2 | 2014 | 4 | 0.170 |
Why?
| | Risk | 1 | 2017 | 232 | 0.170 |
Why?
| | Brain | 1 | 2006 | 1574 | 0.160 |
Why?
| | Catheterization, Central Venous | 1 | 2017 | 44 | 0.160 |
Why?
| | Anxiety Disorders | 1 | 2018 | 175 | 0.160 |
Why?
| | Thromboembolism | 1 | 2017 | 38 | 0.160 |
Why?
| | Parents | 1 | 2018 | 102 | 0.160 |
Why?
| | Resilience, Psychological | 2 | 2014 | 22 | 0.160 |
Why?
| | Thrombosis | 1 | 2017 | 68 | 0.160 |
Why?
| | Psychiatric Nursing | 1 | 2018 | 145 | 0.150 |
Why?
| | Heart Diseases | 1 | 2017 | 102 | 0.150 |
Why?
| | Interviews as Topic | 1 | 2015 | 148 | 0.150 |
Why?
| | Escape Reaction | 1 | 2014 | 4 | 0.140 |
Why?
| | Personality Disorders | 1 | 2013 | 21 | 0.130 |
Why?
| | Interpersonal Relations | 2 | 2012 | 117 | 0.130 |
Why?
| | Risk Assessment | 2 | 2020 | 804 | 0.130 |
Why?
| | Psychology, Military | 1 | 2013 | 1 | 0.130 |
Why?
| | Physicians, Primary Care | 1 | 2013 | 4 | 0.130 |
Why?
| | Repression, Psychology | 1 | 2013 | 3 | 0.130 |
Why?
| | Medical History Taking | 1 | 2013 | 26 | 0.130 |
Why?
| | Physician's Role | 1 | 2013 | 22 | 0.130 |
Why?
| | Mental Status Schedule | 1 | 2013 | 121 | 0.130 |
Why?
| | Acrosome | 1 | 1992 | 1 | 0.130 |
Why?
| | Spermatocytes | 1 | 1992 | 1 | 0.130 |
Why?
| | GTP-Binding Proteins | 1 | 1992 | 13 | 0.130 |
Why?
| | Mass Behavior | 1 | 2012 | 1 | 0.120 |
Why?
| | Social Change | 1 | 2012 | 4 | 0.120 |
Why?
| | Age Factors | 2 | 2020 | 941 | 0.120 |
Why?
| | Physical Examination | 1 | 2013 | 112 | 0.120 |
Why?
| | Risk Factors | 4 | 2014 | 2611 | 0.120 |
Why?
| | Personality | 1 | 2013 | 68 | 0.120 |
Why?
| | Aged, 80 and over | 2 | 2019 | 5172 | 0.120 |
Why?
| | Neuropsychological Tests | 2 | 2006 | 1278 | 0.110 |
Why?
| | Cross-Cultural Comparison | 1 | 2011 | 40 | 0.110 |
Why?
| | Psychology | 1 | 2011 | 24 | 0.110 |
Why?
| | Competency-Based Education | 1 | 2010 | 16 | 0.110 |
Why?
| | Drug Resistance | 1 | 2009 | 67 | 0.100 |
Why?
| | Interview, Psychological | 1 | 2009 | 45 | 0.100 |
Why?
| | Child, Abandoned | 1 | 2009 | 2 | 0.100 |
Why?
| | Animals | 2 | 2017 | 5221 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 266 | 0.100 |
Why?
| | Cohort Studies | 2 | 2019 | 1959 | 0.090 |
Why?
| | Free Association | 1 | 2008 | 1 | 0.090 |
Why?
| | Austria | 3 | 2014 | 8 | 0.090 |
Why?
| | Feasibility Studies | 2 | 2019 | 283 | 0.090 |
Why?
| | Qualitative Research | 2 | 2019 | 118 | 0.090 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 361 | 0.090 |
Why?
| | Psychoses, Substance-Induced | 1 | 2007 | 4 | 0.090 |
Why?
| | Encephalitis, Herpes Simplex | 1 | 2007 | 2 | 0.090 |
Why?
| | Risperidone | 1 | 2007 | 5 | 0.090 |
Why?
| | Haloperidol | 1 | 2007 | 32 | 0.090 |
Why?
| | Hyperkinesis | 1 | 2007 | 12 | 0.090 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 14 | 0.090 |
Why?
| | Heart Rate | 1 | 2008 | 165 | 0.090 |
Why?
| | Electroshock | 1 | 2006 | 1 | 0.080 |
Why?
| | Mood Disorders | 1 | 2007 | 36 | 0.080 |
Why?
| | Inclusion Bodies | 1 | 2006 | 15 | 0.080 |
Why?
| | Tauopathies | 1 | 2006 | 15 | 0.080 |
Why?
| | Puberty, Precocious | 1 | 2006 | 1 | 0.080 |
Why?
| | Fatal Outcome | 1 | 2006 | 76 | 0.080 |
Why?
| | Atrophy | 1 | 2006 | 107 | 0.080 |
Why?
| | Diagnostic Errors | 1 | 2006 | 48 | 0.080 |
Why?
| | Psychopharmacology | 1 | 2006 | 2 | 0.080 |
Why?
| | Logistic Models | 2 | 2020 | 479 | 0.080 |
Why?
| | Drug Interactions | 1 | 2005 | 71 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 527 | 0.080 |
Why?
| | Hyperlipidemias | 1 | 2005 | 27 | 0.080 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 83 | 0.080 |
Why?
| | Adaptation, Psychological | 2 | 2019 | 178 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2006 | 469 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 2018 | 391 | 0.070 |
Why?
| | Depressive Disorder, Major | 1 | 2005 | 109 | 0.070 |
Why?
| | Piperazines | 1 | 2005 | 98 | 0.070 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2007 | 190 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2004 | 181 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2007 | 1233 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 421 | 0.070 |
Why?
| | Illinois | 1 | 2004 | 268 | 0.070 |
Why?
| | Life Change Events | 2 | 2014 | 42 | 0.070 |
Why?
| | Health Care Surveys | 1 | 2003 | 76 | 0.070 |
Why?
| | Disease Progression | 1 | 2006 | 851 | 0.070 |
Why?
| | Activities of Daily Living | 1 | 2006 | 472 | 0.060 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2017 | 386 | 0.060 |
Why?
| | Africa | 2 | 2014 | 12 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2017 | 3456 | 0.060 |
Why?
| | Parenting | 2 | 2018 | 72 | 0.060 |
Why?
| | State Medicine | 1 | 2001 | 3 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2006 | 876 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 1244 | 0.050 |
Why?
| | Unified Medical Language System | 1 | 2020 | 1 | 0.050 |
Why?
| | Marijuana Abuse | 1 | 2020 | 6 | 0.050 |
Why?
| | Tobacco Use | 1 | 2020 | 7 | 0.050 |
Why?
| | Medical Records | 1 | 2020 | 40 | 0.050 |
Why?
| | United States Department of Veterans Affairs | 1 | 2019 | 11 | 0.050 |
Why?
| | Text Messaging | 1 | 2019 | 14 | 0.050 |
Why?
| | Academic Medical Centers | 1 | 2020 | 162 | 0.050 |
Why?
| | Psychological Techniques | 1 | 2018 | 1 | 0.050 |
Why?
| | Population | 1 | 2018 | 4 | 0.050 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 362 | 0.050 |
Why?
| | ROC Curve | 1 | 2019 | 155 | 0.050 |
Why?
| | Quality of Health Care | 1 | 2020 | 135 | 0.050 |
Why?
| | Afghan Campaign 2001- | 1 | 2017 | 7 | 0.050 |
Why?
| | Parent-Child Relations | 1 | 2018 | 35 | 0.050 |
Why?
| | Iraq War, 2003-2011 | 1 | 2017 | 10 | 0.040 |
Why?
| | Psychometrics | 1 | 2019 | 286 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 594 | 0.040 |
Why?
| | Pilot Projects | 1 | 2019 | 440 | 0.040 |
Why?
| | Checklist | 1 | 2017 | 41 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2019 | 694 | 0.040 |
Why?
| | Health Promotion | 1 | 2019 | 183 | 0.040 |
Why?
| | Central Venous Catheters | 1 | 2017 | 3 | 0.040 |
Why?
| | India | 1 | 2017 | 25 | 0.040 |
Why?
| | Focus Groups | 1 | 2017 | 91 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2019 | 875 | 0.040 |
Why?
| | Methylphenidate | 1 | 2016 | 8 | 0.040 |
Why?
| | Mothers | 1 | 2018 | 178 | 0.040 |
Why?
| | Research | 1 | 2016 | 62 | 0.040 |
Why?
| | Autopsy | 1 | 2017 | 334 | 0.040 |
Why?
| | Family Relations | 1 | 2014 | 13 | 0.030 |
Why?
| | Sex Distribution | 1 | 2014 | 91 | 0.030 |
Why?
| | Age Distribution | 1 | 2014 | 116 | 0.030 |
Why?
| | Virulence Factors, Bordetella | 1 | 1992 | 2 | 0.030 |
Why?
| | Spermatids | 1 | 1992 | 2 | 0.030 |
Why?
| | Pertussis Toxin | 1 | 1992 | 4 | 0.030 |
Why?
| | Cell Compartmentation | 1 | 1992 | 12 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1992 | 24 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 1992 | 36 | 0.030 |
Why?
| | Antibodies | 1 | 1992 | 73 | 0.030 |
Why?
| | Self Report | 1 | 2013 | 217 | 0.030 |
Why?
| | Yugoslavia | 1 | 2011 | 2 | 0.030 |
Why?
| | Turkey | 1 | 2011 | 5 | 0.030 |
Why?
| | Family Characteristics | 1 | 2011 | 17 | 0.030 |
Why?
| | Motivation | 1 | 2011 | 98 | 0.030 |
Why?
| | Child Welfare | 1 | 2009 | 20 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2014 | 2046 | 0.020 |
Why?
| | Mice | 1 | 1992 | 1843 | 0.020 |
Why?
| | Child Abuse, Sexual | 1 | 2006 | 17 | 0.020 |
Why?
| | Drug Compounding | 1 | 2005 | 5 | 0.020 |
Why?
| | Expert Testimony | 1 | 2005 | 14 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2005 | 45 | 0.020 |
Why?
| | Bipolar Disorder | 1 | 2005 | 136 | 0.020 |
Why?
|
|
Karnik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|